Table 3.
Adjusted Linear Regression Models: Association of BAUD Intensity and >6 Months of MAUD with Pre- to Post-Treatment Change in CD4, Log VL, VACS Index Score 2.0, and ARV Adherence*
Detectable VL | Undetectable VL | |||
---|---|---|---|---|
Treatment Intensity | Coef | 95% CI | Coef | 95% CI |
CD4 change | n=2139 | n=2802 | ||
>6 Months of MAUD | 27.09 | 1.40–52.79 | −10.5 | −31.3–10.3 |
1 Day Only (referent group) | ||||
Minimal | 15.77 | −1.06–32.61 | 2.05 | −12.76–16.86 |
Moderate | 30.11 | 9.20–51.01 | −2.75 | −23.30–17.80 |
Intensive | 27.60 | −10.20–65.41 | −10.4 | −53.53–32.64 |
P=.03 | P=.9 | |||
Log HIV-1 RNA change | n=2176 | n=2869 | ||
>6 Months of MAUD | −0.16 | −0.32–0.01 | −0.08 | −0.23–0.06 |
1 Day Only (referent group) | ||||
Minimal | −0.07 | −0.18–0.04 | −0.02 | −0.13–0.08 |
Moderate | 0.01 | −0.13–0.15 | 0.06 | −0.09–0.20 |
Intensive | −0.40 | −0.66–(−0.14) | 0.03 | −0.27–0.33 |
P=.01 | P=.7 | |||
VACS Index Score 2.0 change | n=2053 | n=2460 | ||
>6 Months of MAUD | −0.94 | −2.69–0.81 | −.30 | −1.42–0.83 |
1 Day Only (referent group) | ||||
Minimal | −0.55 | −1.67–0.57 | −0.18 | −0.97–0.60 |
Moderate | −0.71 | −2.11–0.69 | 0.62 | −0.48–1.71 |
Intensive | −3.79 | −6.45–(−1.13) | −0.03 | −2.25–2.20 |
P=.047 | P=.5 | |||
ARV Adherence change** | n=1649 | n=2827 | ||
>6 Months of MAUD | 0.05 | 0.02–0.08 | 0.04 | 0.02–0.05 |
1 Day Only (referent group) | ||||
Minimal | 0.01 | −0.01–0.03 | −0.00 | −0.01–0.01 |
Moderate | 0.03 | 0.00–0.05 | −0.01 | −0.02–0.01 |
Intensive | 0.09 | 0.04–0.15 | 0.08 | 0.05–0.12 |
P=.004 | P<.001 |
Models are adjusted for age and race/ethnicity, gender, smoking, HCV, drug diagnosis, severe mental illness (SMI), AUDIT-C, and for corresponding models, number of days between pre and post values for log VL, CD4, and VACS Index change.